Business
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\n Los Angeles, CA, March 23, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a medical device company known for its innovative and effective pain management solutions -- announced today that it is entering the final stages of clearance to receive a Taiwan FDA (TFDA) License for Medical Devices to distribute its flagship product, SofPulse® in Taiwan. Sofpulse® medical devices are designed to accelerate recovery and reduce pain and edema post operatively. SofPulse® technology uses a non-invasive Pulsed Electro-Magnetic Field (PEMF) therapy that uses low-frequency electromagnetic fields to stimulate the body's natural healing processes, stimulate circulation and speed up the healing process. With its launch in Taiwan on the horizon, Sofpulse® is poised to help more patients experience the benefits of this revolutionary technology. SofPulse® Partners with Taiwan Distributor Evermed Medical Enterprises Co. Evermed is a Taiwanese medical device distributor that provides a wide range of medical products and services to hospitals, clinics and healthcare professionals. Established in 2012, Evermed has an extensive network of contacts throughout the Taiwanese surgical market and is known for its expertise in medical device distribution. Ira Weisberg, President of Endonovo’s Medical Division, said: \"We are proud to partner with Evermed to bring the SofPulse® device to Taiwan, a market known for its focus on patient care and medical innovation. Our global mission is to provide healthcare professionals with the best tools possible to help patients recover quickly and effectively. We are confident that Evermed's expertise and network in the Taiwanese market will make a significant impact on the health and well-being of patients in the region.” Evermed’s Chief Executive Officer, George Wang, commented: “Evermed feels that the SofPulse® device with its proven results in successfully reducing pain and edema in surgical operations is the best product to offer our Taiwanese distribution network. We are excited to partner with Endonovo to introduce SofPulse®-- a proven drug-free, postoperative pain and edema reduction device -- to the Taiwanese surgical market.” Evermed Taiwanese Medical Device Distributor Evermed is a medical device distributor that speci...